Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis

Clinical Microbiology and Infection

Volumn 11, Issue 4, 2005, Pages 296-300

  Lortholary, O ^a   Sitbon, K ^a   Dromer, F ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Cryptococcus neoformans; Cytokines; Fungaemia; Inflammation; TNF receptors; Virus load

Indexed keywords

ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYTOKINE; FUNGUS ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; BLOOD; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DEATH; DISEASE SEVERITY; FEMALE; FUNGEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; T LYMPHOCYTE; TITRIMETRY; VIRUS LOAD;

FILOBASIDIELLA NEOFORMANS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 15944366222     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01074.x     Document Type: Article

References (15)

1. Witt MD, Lewis RJ, Larsen RA et al. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 1996; 22: 322-328.
2. Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor alpha in human leukocytes, stimulated by Cryptococcus neoformans. Infect Immun 1994; 62: 1975-1981.
3. Vecchiarelli A, Retini C, Monari C, Tascini C, Bistoni F, Kozel TR. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 1996; 64: 2846-2849.
4. Harrison TS, Levitz SM. Mechanisms of impaired anti-cryptococcal activity of monocytes from donors infected with human immunodeficiency virus. J Infect Dis 1997; 176: 537-540.
5. Pietrella D, Monari C, Retini C, Palazzetti B, Kozel TR, Vecchiarelli A. HIV type 1 envelope glycoprotein gp120 induces development of a T helper type 2 response to Cryptococcus neoformans. AIDS 1999; 13: 2197-2207.
6. Pettoello-Mantovani M, Casadevall A, Kollmann TR, Rubinstein A, Goldstein H. Enhancement of HIV-1 infection by the polysaccharide of Cryptococcus neoformans. Lancet 1992; 339: 21-23.
7. Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63: 1725-1731.
8. Chaka WS, Heyderman R, Gangaidzo I et al. Cytokine profiles in CSF and plasma of HIV-infected patients with cryptococcal meningitis: no leucocytosis despite high IL-8 levels. J Infect Dis 1997; 176: 1633-1636.
9. Lortholary O, Dromer F, Mathoulin-Pélissier S et al. Immune mediators in cerebrospinal fluid are influenced by meningeal involvement and human immunodeficiency virus serostatus during Cryptococcus neoformans infection. J Infect Dis 2001; 183: 294-302.
10. Lortholary O, Improvisi L, Rayhane N et al. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun 1999; 67 6314-6320.
11. Monari C, Casadevall A, Pietrella D, Bistoni F, Vecchiarelli A. Neutrophils from patients with advanced human immunodeficiency virus infection have impaired complement receptor function and preserved Fc-g receptor function. J Infect Dis 1999; 180: 1542-1549.
12. Coenjaerts FEJ, Walenkamp AME, Mwinzi PN et al. Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. J Immunol 2001; 167: 3988-3995.
13. Pietrella D, Kozel TR, Monari C, Bistoni F, Vecchiarelli A. Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans. J Infect Dis 2001; 183: 51-58.
14. Monari C, Casadevall A, Baldelli F et al. Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy. AIDS 2000; 14: 2699-2708.
15. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994; 169: 420-424.